CASI Pharmaceuticals, Inc.

CASINASDAQ Capital Market·USD·Closed

CASINASDAQ·USD·Closed

$0.15

+3.08%

$0.15

+$0.00 (3.08%)

52W Range

1thpctl

Volume

0.04×avg

Mkt Cap

2.33MUSD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.04×avg

Market Cap

2.33MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-15.8% / yr

Operating margin-168.0%

ROIC-1157.5%

Financially safe

Stretched

Debt / equity-0.66×

Interest coverage-70.9×

Current ratio0.30×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required